ABSTRACT
BACKGROUND AND PURPOSE: There are limited indicators available to predict cerebral vasospasm in patients with subarachnoid hemorrhage (SAH). The purpose of this study was to determine if CT perfusion-derived hemodynamic parameters are predictors of vasospasm severity and outcome after experimental SAH. MATERIALS AND METHODS: SAH was induced in 25 New Zealand white rabbits. Cerebral blood flow (CBF), cerebral blood volume (CBV), and mean transit time (MTT) were measured with CT perfusion before SAH, within 1 hour after SAH, and on days 2, 4, 7, 9, and 16 after SAH. Basilar artery diameter, measured with CT angiography and neurologic scoring, was also obtained on the same days. Differences between animals with moderate-severe delayed vasospasm (>/=24% basilar artery narrowing) and mild delayed vasospasm (<24% basilar artery narrowing) were investigated with repeated measures analysis of variance. Multiple linear regression analysis was used to investigate the relationship between CT perfusion parameters (CBF, CBV, MTT), basilar artery diameter, and neurologic score. RESULTS: MTT increase <1 hour after SAH independently predicted mortality within 48 hours of SAH (P < .05). MTT and neurologic deficits were significantly greater with moderate-severe than with mild vasospasm (P < .05). MTT on day 2, but not CBF or CBV, was a significant predictor of subsequent moderate-severe delayed vasospasm (P < .05). CONCLUSION: In the rabbit model of experimental SAH, the CT-derived hemodynamic parameter MTT on day 0 predicted early mortality, and MTT on day 2 predicted development of moderate-severe delayed vasospasm. MTT was also significantly correlated with arterial diameter and neurologic score.
Subject(s)
Disease Models, Animal , Radiographic Image Interpretation, Computer-Assisted/methods , Subarachnoid Hemorrhage/complications , Subarachnoid Hemorrhage/diagnostic imaging , Tomography, X-Ray Computed/methods , Vasospasm, Intracranial/diagnostic imaging , Vasospasm, Intracranial/etiology , Animals , Perfusion/methods , Prognosis , Rabbits , Survival Analysis , Survival Rate , Treatment OutcomeABSTRACT
BACKGROUND AND PURPOSE: Nimodipine is a therapy that reduces morbidity and mortality in patients with subarachnoid hemorrhage (SAH), though the mechanisms by which it does so are not well understood. In a rabbit model of SAH, we studied the effects of nimodipine by using functional CT imaging. We hypothesized that the nimodipine treatment group would have (1) increased mean basilar artery diameter, (2) less diminished cerebral blood flow (CBF) following vasospasm, and (3) better neurologic outcomes. METHODS: SAH was induced in 26 New Zealand White rabbits randomized to 2 groups: treated (nimodipine) or control (no treatment). CT perfusion and CT angiography were used to measure CBF and basilar artery diameter at baseline, 10, 30, and 60 minutes after SAH, and on days 3, 5, 7, 9, and 16. Neurologic assessments were performed on each day of scanning. RESULTS: Basilar artery diameter in the treated group was greater than in the control group post-SAH (P < .05). When vasospasm was >15%, CBF in the nimodipine group was significantly greater than in the control group in the brain stem, cerebellum, parieto-occipital cerebrum, and deep gray matter (P < .05). Neurologic scores in the nimodipine group were significantly better than in the control group on days 5 and 9 (P < .05). CONCLUSION: Animals treated with nimodipine showed (1) increased mean basilar artery diameter, (2) improved neurologic outcome, and (3) increased mean CBF despite no significant difference in the incidence and severity of delayed vasospasm. These data provide a basis for future studies comparing the efficacy of new treatments for SAH to that of nimodipine.
